title: Protein-energy malnutrition decreases immune response to Leishmania chagasi vaccine in BALB/c mice.
abstract: Protein-energy malnutrition and visceral leishmaniasis are important problems of public health affecting millions of people worldwide. Vaccine efficacy depends on the ability of individuals to mount an appropriate immune response and may be inadequate in malnourished persons. In this study, we used a mouse model to verify the effect of combined protein, iron and zinc deficiency in the response to Leishmania chagasi antigen vaccine. BALB/c mice were fed with a low-protein (3% casein), iron- and zinc-deficient diet or control diet (14% casein and sufficient in zinc and iron). After malnutrition establishment, mice were vaccinated subcutaneously with L. chagasi Ag plus saponin. After vaccination, mice were nutritionally repleted and then all mice were challenged with L. chagasi promastigotes. Four weeks later, liver and spleen parasite load was evaluated. Our data show that vaccine caused a significant reduction in parasite load in spleen and liver from mice fed with control diet. However, splenic parasitism was increased in mice fed with deficient diet and this diet caused a reduction in splenocyte IFN-gamma production in response to the vaccine in repleted mice. These data suggest that malnutrition may alter immune response to L. chagasi vaccine in BALB/c model of infection, even after nutritional repletion.
authors.affiliation: Laboratório de Imunoparasitologia, Núcleo de Pesquisa em Ciências Biológicas (NUPEB), Universidade Federal de Ouro Preto (UFOP), Ouro Preto, Brazil. guilherme@nupeb.ufop.br
authors.forename: G
authors.initials: G
authors.lastname: Malafaia
authors.forename: T D
authors.initials: TD
authors.lastname: Serafim
authors.forename: M E
authors.initials: ME
authors.lastname: Silva
authors.forename: M L
authors.initials: ML
authors.lastname: Pedrosa
authors.forename: S A
authors.initials: SA
authors.lastname: Rezende
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000818:Animals; D000953:Antigens, Protozoan / Q000276:immunology; D001835:Body Weight; D004032:Diet; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D007371:Interferon-gamma / Q000096:biosynthesis; D000090463:Iron Deficiencies; D018314:Leishmania infantum / Q000276:immunology*; D054332:Leishmaniasis Vaccines / Q000276:immunology*; D008099:Liver / Q000469:parasitology; D008214:Lymphocytes / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D011502:Protein-Energy Malnutrition / Q000276:immunology*; D012503:Saponins / Q000008:administration & dosage; D013154:Spleen / Q000469:parasitology; D016019:Survival Analysis; D015032:Zinc / Q000172:deficiency
chemical_list: D000276:Adjuvants, Immunologic; D000953:Antigens, Protozoan; D054332:Leishmaniasis Vaccines; D012503:Saponins; D007371:Interferon-gamma; D015032:Zinc